GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sofgen Pharma PROCF · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.03

—

Close of 29 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Sofgen Pharma

Our reporting

We have not reported on Sofgen Pharma yet.

Next results

30 Dec 2026

Due on 30 Dec 2026. Analysts expect earnings of 0.16 a share on revenue of $135.7m.

Past results

Reported against what analysts expected

26 Dec 20235 Sept 20239 Jun 202314 Nov 202230 Aug 20222 Jun 2022
Earnings per share0.050.09-0.080.010.020.01
Forecast0.050.06-0.040.130.100.01
Revenue$118.0m$110.0m$84.0m$110.4m$112.4m$85.6m
Forecast$110.4m$112.4m$83.6m$118.0m$112.2m$88.3m

Key events

  1. 30 Sept 20211-to-1 reverse split
  2. 9 Dec 2019Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.